POL HCQ ethics
K |
|||
| Zeile 6: | Zeile 6: | ||
{{tp|p=32451256|t=2020. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?|pdf=|usr=011}} | {{tp|p=32451256|t=2020. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?|pdf=|usr=011}} | ||
{{tp|p=32467095|t=2020. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk.|pdf=|usr=007}} | {{tp|p=32467095|t=2020. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk.|pdf=|usr=007}} | ||
| + | {{tp|p=32471832|t=2020. Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis.|pdf=|usr=007}} | ||
| + | {{tp|p=32542496|t=2020. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.|pdf=|usr=011}} | ||
Version vom 6. Dezember 2020, 10:36 Uhr
32279469 2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.
32238355 2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.
32294807 2020. Hydroxychloroquine use during the COVID-19 pandemic 2020.
32389025 2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
32450097 2020. Prescription Restrictions on Hydroxychloroquine Among the Largest Florida Pharmacy Chains During the COVID-19 Pandemic: An Observational Study.
32451256 2020. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
32467095 2020. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk.
32471832 2020. Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis.
32542496 2020. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
